Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Teens on the horizon, gold ahead.
Hold for gold.
For what it's worth, it's pretty much a guarantee that institutions will get involved here once the transfer of control is complete.
Most mergers on the OTC are suspicious at best.
Investors now have a chance to get in on the ground floor of a stable company in an emerging and rapidly expanding market. Most still haven't caught on; this shouldn't just be a trade, but an investment.
Dividends are common in Asia, and management has expressed sympathy towards this idea. Some could do very well here with enough gumption,
People don't realize how much upside there is with pharmaceutical companies in this region. Few sectors are growing faster. The few companies of this sort that do trade publicly perform exceptionally well, with very high market caps.
We can probably expect the financials in the coming weeks.
Some profit takers are to be expected, but we've not seen insider selling on a large scale.
A high of .0777? That's a sign if ever I saw one.
It's a mystery why anyone would sell at these levels - the chart suggests much higher levels in the near future.
Financials should be coming very shortly, most will be impressed.
Only a matter of time here.
$1.00 is definitely possible here as things develop
Float is locked up, and I doubt we'll see much insider selling this year. The right people just need to find this gem.
100 possible reasons for this, but it's best to shake the weaker hands at these levels anyway.
I've no concerns here
Yes, and I honestly don't think we'll see any real insider selling here.
Delex is an established pharmaceutical company with a history going back to 2009. Most of what they've done is incredibly well documented.
Please, see this link for more details: https://delexpharma.com/delex-through-the-years
Obviously going to skyrocket once the audited financials are dropped. It's not difficult to find proof that confirms the story here.
Great news, I just hope the right people see it.
It was a good week, all things considered, and some weak hands are to be expected at this stage.
The real run should begin in September, once the new CEO comes in, financials are confirmed, and so on.
Anyone who sells at these levels is bound to regret it
Even though I'm relatively loaded, I'm still building my position as well.
I truly believe that dollars may be possible here, but we'll doubtlessly encounter shenanigans on the way up. The main event hasn't even begun,
A wise decision, if you're being honest. Someone clearly wanted to take us down at the end of the day here, which is a good sign. Some might want to continue to load under ,03, artificially lowering the price.
Realistically, anything under .05 is gold here. I truly believe we'll see $1.00 in the near future.
By the end of Q3.
The real run hasn't even started.
Once those financials are dropped, all bets are off - one of the only fully legitimate mergers I've seen on the OTC in my time.
Gearing up for the great leap forward.
Genuine NASDAQ potential once all is wrapped up here; they'll likely be one of the few to qualify.
Just the beginning here, and people will want to get in while they have the chance.
I obviously don't have permission to post these forms here.
However, I will post some public evidence to support the claims made in the press releases in the near future.
Every single license shown there is legitimate, not photoshopped, and I've actually seen confirmation of this.
It's okay - your skepticism may be wise in other situations, but not here. This is one of the cleanest mergers to ever hit the OTC; when the dividend hits, you'll wish you bought in at these levels.
Doesn't matter at all.
Audited financials will be dropped, the merger completed, ticker symbol changed, likely to be followed by a dividend. The shares are worth their weight in gold - if people don't see the value, it's their miss.
Many eyes on this stock, waiting for entry, but this is likely the best price they'll get.
BNCM Announces Strategic Partnership between DELEX and VERATHON
Delex Pharma has announced a new distributorship agreement with Verathon to market its advanced and. Innovative video laryngoscopes GLIDESCOPE GO, including the GlideScope Titanium Reusable and GlideScope Spectrum Single-use models.
Strategic Partnership
Verathon, as Delex Pharma's esteemed strategic partner, is renowned for its 40 years of innovation and excellence in the medical field, consistently delivering high-quality products and services to its global network of partners. This partnership represents the pinnacle of Delex's commitment to advancing medical technology in the country.
https://www.otcmarkets.com/stock/BNCM/news/BNCM-Announces-Strategic-Partnership-between-DELEX-and-VERATHON?id=451194
Chart is set up very nicely,
Audited financials should be presented shortly.
.10+ in September is basically guaranteed, as per my discussions with management.
No real concerns here, the merger is a done deal.
Should be receiving some updates this week from management.
A close at .02 or so should be doable here. Float is locked.
Float looks to be locked up, won't take much to make it run